Significant Accounting Policies and Basis of Presentation - Schedule of Schedule of Diluted Net Loss Per Share Antidilutive (Details) - shares |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Total | 3,194,513 | 5,889 | 5,889 | 6,842 |
| Warrant [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Total | 3,126,574 | 1,142 | 1,142 | 384 |
| Convertible Series A Preferred Shares [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Total | 6,458 | |||
| Equity Option [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Total | 67,939 | 4,747 | 4,747 | |